Chef Eric Ripert reminisces on his late friend Anthony Bourdain’s cooking skills in an interview with PEOPLE ahead of the ...

Management reaffirmed 2026 adjusted guidance of total revenues of EUR 2 billion to EUR 2.3 billion, adjusted R&D expenses of EUR 2.2 billion to EUR 2.5 billion, and adjusted SG&A expenses of EUR 700 ...

BioNTech BNTX-0.47%decrease; down pointing triangle plans to shrink its workforce and manufacturing network, as the German biotech company seeks to cut costs and downsize its footprint after demand ...

In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German company BioNTech is slashing a large chunk of its manufacturing footprint, ...

LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too ...

BioNTech (BNTX), the partner of Pfizer (PFE) for the Comirnaty COVID-19 vaccine, fell 18% in the premarket on Tuesday after its Q4 2025 financials, as its full-year outlook fell short of Street ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — The co-founders of the ...

BioNTech SE is flexible about its future structure as it prepares to bring a slew of cancer drugs to market, with its chief executive officer saying he would consider a deal with a partner that gets ...

PHILADELPHIA--(BUSINESS WIRE)--The University of Pennsylvania (“Penn”), BioNTech SE (“BioNTech”), and OUP (Osage University Partners) announced the launch of the $50 million Penn-BioNTech Innovative ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of BioNTech is pictured at Biontech's research laboratory for individualised vaccines against cancer in Mainz, Germany, ...

When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some financial analysts said the buyout amounted to an out-of-court settlement of ...

Covid-19 vaccine makers Moderna and BioNTech became household names almost overnight. Moderna and BioNTech have spent their Covid vaccine windfalls differently, with Moderna investing in its own mRNA ...